A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.
Public ClinicalTrials.gov record NCT00274560. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol in a 12 Week, Randomized, Double-Blind, Double-Dummy Parallel Group Study in Patients With Chronic Obstructive Pulmonary Disease (COPD).
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the study was to evaluate the degree of improvement in lung function in patients with chronic obstructive pulmonary disease (COPD) after treatment with tiotropium inhalation capsules compared to salmeterol inhalation aerosol .
Study identification
- NCT ID
- NCT00274560
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 653 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 1, 2002 (Actual)
- Primary completion
- Mar 27, 2003 (Actual)
- Completion
- Not listed
- Last update posted
- Dec 1, 2023
Started 2002
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Medical Center | Birmingham | Alabama | — | — |
| Boehringer Ingelheim Investigational Site | Jasper | Alabama | — | — |
| Boehringer Ingelheim Investigational Site | Phoenix | Arizona | — | — |
| Southern Arizona VA Health Care System | Tucson | Arizona | — | — |
| Boehringer Ingelheim Investigational Site | Fullerton | California | — | — |
| VA Greater Los angeles Health Care Systems | Sepulveda | California | — | — |
| Olive View UCLA Medical Center | Sylmar | California | — | — |
| Boehringer Ingelheim Investigational Site | Boulder | Colorado | — | — |
| Colorado Pulmonary Associates | Denver | Colorado | — | — |
| Boehringer Ingelheim Investigational Site | Wheat Ridge | Colorado | — | — |
| Boehringer Ingelheim Investigational Site | Melbourne | Florida | — | — |
| Boehringer Ingelheim Investigational Site | Pembroke Pines | Florida | — | — |
| University Medical Associates, LLP | Augusta | Georgia | — | — |
| Boehringer Ingelheim Investigational Site | Coeur d'Alene | Idaho | — | — |
| LSU MC-Sheveport | Shreveport | Louisiana | — | — |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | — | — |
| The Oregon Clinic | Portland | Oregon | — | — |
| Temple University School of Medicine | Philadelphia | Pennsylvania | — | — |
| Attention: Thomas D. Kaelin, Jr., D.O. | Charleston | South Carolina | — | — |
| Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00274560, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2023 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00274560 live on ClinicalTrials.gov.